about
The Role of Sleep and Sleep Disorders in the Development, Diagnosis, and Management of Neurocognitive DisordersInflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstreamQuantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis.Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study.Cross-sectional study of sleep quantity and quality and amnestic and non-amnestic cognitive function in an ageing population: the English Longitudinal Study of Ageing (ELSA).Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies.Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populationsAssociation of inflammatory markers with cardiovascular risk and sleepiness.Are short bad sleep nights a hindrance to a healthy heart?Cross-sectional versus prospective associations of sleep duration with changes in relative weight and body fat distribution: the Whitehall II StudyGender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study.Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitusNonpharmacological Treatments of Insomnia for Long-Term Painful Conditions: A Systematic Review and Meta-analysis of Patient-Reported Outcomes in Randomized Controlled Trials.Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine.Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study.Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II Study.Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study.The paraoxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or INCHIANTI studies.Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study.Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction.Cellular adhesion molecules and blood pressure: interaction with sex in a multi-ethnic population.Association between IL6 gene variants -174G>C and -572G>C and serum IL-6 levels: interactions with social position in the Whitehall II cohort.Sleep and Cardio-Metabolic Disease.Molecular variants of the sodium/hydrogen exchanger type 3 gene and essential hypertension.Ethnic differences in circulating soluble adhesion molecules: the Wandsworth Heart and Stroke Study.Comparisons of spot vs 24-h urine samples for estimating population salt intake: validation study in two independent samples of adults in Britain and Italy.Reducing cholesterol and atherosclerosis: the importance of cellular adhesion molecules?Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites.Sleep and mortality: cause, consequence, or symptom?Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population.Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population.Circulating soluble E-selectin levels and the Ser 128Arg polymorphism in individuals from different ethnic groups.Genetic variants of Y chromosome are associated with a protective lipid profile in black men.Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population.Association of sleep duration and quality with blood lipids: a systematic review and meta-analysis of prospective studies.Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarction--the impact of migration as a modBiomarkers of cardiovascular risk in sleep-deprived people.A new challenge to widely held views on the role of sleep.Is prolonged lack of sleep associated with obesity?Relationships between sleep duration and von Willebrand factor, factor VII, and fibrinogen: Whitehall II study.
P50
Q26777958-895A95F3-74BA-4993-B8BC-FC07A4CC2CA1Q28473422-FC184B02-2AB7-41DE-B5D0-E13D17F2094FQ30884041-576056B3-EAA8-4F77-B78F-6E37763A1705Q33361648-C1FAC2DA-96FA-480E-A061-0D240DF8EF90Q33812753-F731F486-7935-4BF4-BEEC-F25101F14BC2Q33814169-F26CDB96-BFB7-419E-8900-A2BDF4D2766CQ33939456-30AEAEE9-073E-40A6-9D56-AE5B6AE73A28Q35306451-54593582-DE7A-4771-BFAE-628DDE83C4C4Q35406893-58C55C66-7BA0-4D39-A0D8-B601D527624FQ35503444-7587DC66-C00F-473D-A5E2-30DD876EC703Q35566917-F0796767-3BDF-4835-BC00-2666EECB34F8Q35830087-0DDF4DED-C52D-4F1F-ACDE-6B616DF6F787Q36744133-E35B2E82-66CD-438E-B5A6-D9CC7C6A5929Q37236427-539304BC-7638-471A-9D1D-43C4E9641342Q37253222-503E053D-EE48-46D1-92E6-3F73D7AEFB63Q37279596-E30D6308-AE23-4B81-9EF5-8102A913AE7EQ37305908-EF3C794F-0390-4961-B0A1-B3BBD6D57F7DQ37370332-D6B8E0C9-EE3A-4C88-B442-F76F42561234Q37404531-F2D45BAF-F603-48D2-A24F-4B68AFB96088Q37793742-697F1703-2D21-47B6-A19C-B4609D182048Q39684076-172E003D-6065-4AA6-BCA8-079CA8E12970Q40026631-5DE5F2CF-3C0A-4547-9886-0DED6E3B50D6Q42361068-F2F27673-9A9D-423E-9C23-DEEE5511646FQ43666755-B74F5930-FBF3-4BC3-B3A1-532835AFB9C5Q43989950-C8F6BE89-4C3F-4362-8F44-276BF624ACC3Q44117452-2596A54C-62F3-415A-9BB4-4F464604DF15Q44153220-E4512DF0-3B33-45CA-8D4F-719E6C06D23FQ44289112-BB7135EC-C7D0-441F-8FF9-381F84C659AEQ44457717-D2616DB0-ABA5-4BCA-8F34-E6731BC98DB7Q45054440-442604FA-A507-4295-B0FA-DF33FB738705Q46160524-44324146-1363-46AC-95F3-F22F7BD2A048Q46472509-7FB7A852-3A53-4B9A-AB46-BD66D5131862Q46568151-EEC71028-2D01-49B3-95DF-200C87544BBAQ46630425-184A6B76-CD66-4539-9E7B-F157E687451FQ47097711-C131298F-D5A3-4F2C-AA8C-302E7C204032Q47235314-45541C1D-5676-4FEB-8595-A55571F16612Q48182651-366E9C26-5ACF-4240-8BA3-EBAC8C5DAD65Q48217673-122C751E-C604-4935-914B-89B6E5147106Q48300714-8D134828-2217-4C11-B432-360F6392DC5AQ48348005-19EA2482-8564-49B9-A2B1-4E44B586D42F
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Michelle A Miller
@ast
Michelle A Miller
@en
Michelle A Miller
@es
Michelle A Miller
@nl
Michelle A Miller
@sl
type
label
Michelle A Miller
@ast
Michelle A Miller
@en
Michelle A Miller
@es
Michelle A Miller
@nl
Michelle A Miller
@sl
prefLabel
Michelle A Miller
@ast
Michelle A Miller
@en
Michelle A Miller
@es
Michelle A Miller
@nl
Michelle A Miller
@sl
P214
P244
P106
P21
P214
P244
P31
P496
0000-0002-6696-0923
P734
P735
P7859
lccn-n99039794